16th Jul 2008 13:14
16 July 2008
SYNERGY HEALTHCARE PLC ("the Company")
The Company has been notified that the following award of LTIP options has been made, pursuant to the Company's LTIP scheme, to certain Persons Discharging Managerial Responsibility ("PDMR") over 97,273 ordinary shares of 0.625 pence each in the Company ("Ordinary Shares"), as follows:
|
Name |
No. of LTIP options |
Market price per share (£) |
Value (£) |
|
Paul Santing |
34,470 |
7.13 |
245,771 |
|
Michael Fazal |
28.169 |
7.13 |
200,845 |
|
Adrian Coward |
25,245 |
7.13 |
179,997 |
|
Paul Wynne |
9,389 |
7.13 |
66,944 |
In accordance with the LTIP scheme rules for conditional awards, the LTIP options were made based on a share price of 713 pence per Ordinary Share, being the average quoted market price of the Company's shares on the three dealing days prior to the date of grant.
The LTIP options have been granted on a conditional basis and no shareholder rights will be conferred upon the grantee until the LTIP options have vested. Such vesting is subject to the achievement of the performance criteria of the scheme over the three year measurement period to 16 July 2011.
Furthermore, the Company has been notified that the following award of share options have been allocated, pursuant to the Company's Executive Share Option Scheme, to certain PDMRs, over 23,367 Ordinary shares of 0.625 pence each in the Company, as follows:
|
Name |
No. of LTIP options |
Market price per share (£) |
Value (£) |
|
William Evans |
5,785 |
7.13 |
41,247 |
|
Richard Palmowski |
4,694 |
7.13 |
33,468 |
|
Alison Payne |
4,908 |
7.13 |
34,994 |
|
George Dijkstra |
7,980 |
7.13 |
56,897 |
In accordance with the Company's Executive Share Option Scheme, options are exercisable at a price equal to the average quoted market price of the Company's shares on the three dealing days prior to the date of grant. Exercise of the options is subject to performance conditions determined by the Remuneration Committee and are linked to a sustained and significant improvement in the underlying financial performance of the Company over a three year vesting period.
Enquiries
Ivan Jacques (Group Finance Director and Company Secretary) +44 (0) 1793 891 861
Related Shares:
SYR.L